Dr. Anthony Fauci announced Aug. 22 that he will step down from his multiple positions in December. Fauci—director, National Institute of Allergy and Infectious Diseases, chief of the NIAID Laboratory of Immunoregulation and chief medical advisor to President Joe Biden—has served NIH for 54 years.
In the 1940s, a Black woman named Anne had the right test scores to get into medical school but was denied admission due to the color of her skin. Her niece, Janet Stovall, a communications strategist and entrepreneur, paid tribute to Anne in a recent NIMHD lecture by offering insights into inclusion.
Thanks to the convergence of policy and technology, people with disabilities are reimagining how they live and represent themselves, said Dr. Jonathan Kaufman during the inaugural Disability Pride Month virtual lecture on the 32nd anniversary of the Americans with Disabilities Act (ADA).
A collection of eight charcoal portraits, now on display at the Clinical Center, depicts people who have recently died of a drug overdose. Artist Theresa Clower hopes the portraits and narratives, part of a larger project organized by INTO LIGHT, will help change the conversation about addiction.
On the Cover
Penny-sized lab-on-a-chip device capable of quickly detecting the amount and severity of microvascular occlusion, or blood vessel blockage, from a blood droplet taken from people with sickle cell anemia. That blockage, a hallmark of the disease, can lead to organ damage and other complications. Called the microfluidic impedance red cell assay (MIRCA), the device may help test the effectiveness of medicinal treatments and curative therapies for sickle cell disease and ultimately improve outcomes. The device was developed by NHLBI grantee Dr. Umut Gurkan, a biomedical engineering professor at Case Western Reserve University. September is Sickle Cell Disease Awareness Month.